Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ghent, Belgium, B-9000
- University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥18 years
- CKD stage 5 with hemodialysis or hemodiafiltration treatment for more than three months
- Hematocrit >30 %
- Routine anticoagulation and erythropoietin regimen
- No vascular access related problems (A/V-fistula, graft or bi-flow catheter)
- No ongoing infection
- Signed informed consent form
Exclusion Criteria:
- Inclusion criteria not met
- Known HIV or active hepatitis B or C infection (positive PCR). Pregnancy
- Unstable clinical condition (e.g. cardiac or vascular instability)
- Life expectancy less than 12 months
- Known coagulation problems
- Patients participating in another study interfering with the planned study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 1
treatment with dialyzer ELISIO 170H
|
one week of three consecutive dialysis treatments, > 3 hours
|
|
Active Comparator: 2
treatment with dialyzer PES-170DS
|
one week of three consecutive dialysis treatments, > 3 hours
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
protein-bound toxin removal
Time Frame: pre and post dialysis treatment
|
pre and post dialysis treatment
|
|
low-molecular weight protein removal
Time Frame: pre and post dialysis treatment
|
pre and post dialysis treatment
|
|
small solute removal
Time Frame: pre and post dialysis treatment
|
pre and post dialysis treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Raymond Vanholder, Prof. Dr., University Hospital Ghent, Nephrology Section
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- KSEL0702
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.